Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

MAP 2018 – Molecular Analysis for Personalised Therapy

Start date: 14 Sep 2018
End date: 15 Sep 2018
Location: Paris, France

MAP 2018 – Molecular Analysis for Personalised Therapy is a one-of-a-kind meeting designed by a faculty of highly influential key opinion leaders. A truly unique programme will feature speakers with the highest publication track record in the field.

MAP 2018 is the place to network with the leading academic representatives working in personalised medicine for cancer patients.

Create your own personalised agenda and browse the complete scientific programme by day, topic, cancer type and track with the ESMO events app.

MAP 2018 is a joint initiative of Cancer Research UK, UNICANCER and ESMO and aims to provide oncologists with expert guidance on interpreting genomic alterations to design tailored treatment programmes for their patients.

The meeting is highly recommended for medical oncologists, young professionals, academics, regulators, industry R&D representatives and investigators and all those interested in discussing the clinical interpretation of molecular tests with a view to providing effective cancer treatment.